Nyxoah SA Ordinary Shares
NYXH Real Time Price USDRecent trades of NYXH by members of U.S. Congress
---
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes in NYXH holdings by institutional investors
Quarterly net insider trading by NYXH's directors and management
* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.
- 1M
- 3M
- 6M
- YTD
- 1Y
- 2Y
- 5Y
- MAX
About
Key Metrics
Return (1d)
Return (30d)
Return (1Y)
CAGR (Total)
Max Drawdown
Beta
Alpha
Sharpe Ratio
Win Rate
Average Win
Average Loss
Annual Volatility
Annual Std Dev
Information Ratio
Treynor Ratio
Total Trades
Metrics Definitions
Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.
-
Alpha
Measures a portfolio's risk-adjusted performance against that of its benchmark
Learn More about Alpha -
Annual Standard Deviation
Measures how much the portfolio's total return varies from its mean or average.
Learn More about Annual Standard Deviation -
Annual Volatility
A statistical measure of the dispersion of returns for the portfolio.
Learn More about Annual Volatility -
Average Win
The average return (%) for trades that resulted in a positive return.
-
Average Loss
The average return (%) for trades that resulted in a negative return.
-
Beta
A measure of the volatility of the portfolio compared to the market as a whole.
Learn More about Beta -
CAGR
CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.
Learn More about CAGR -
Information Ratio
A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.
Learn More about Information Ratio -
Max Drawdown
the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.
Learn More about Max Drawdown -
Sharpe Ratio
The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.
Learn More about Sharpe Ratio -
Total Trades
The total number of trades made by this strategy.
-
Treynor Ratio
Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.
Learn More about Treynor Ratio -
Win Rate
The percentage of total trades that resulted in a positive return.
Be the first to see our newest insights and key updates across all datasets.
Government lobbying spending instances
NYXH Estimated quarterly lobbying spending
NYXH Revenue by Segment or Geography
New NYXH patent grants
-
Patent Title: Method and system for electrical nerve stimulation Dec. 16, 2025
-
Patent Title: Method and process for placement and fixation of a surgical implant Apr. 15, 2025
-
Patent Title: Arced implant unit for modulation of nerves Jan. 02, 2024
-
Patent Title: Implant unit delivery tool Aug. 22, 2023
-
Patent Title: Programmable external control unit May. 09, 2023
-
Patent Title: Implant holder and suture guide Oct. 25, 2022
-
Patent Title: Control housing for disposable patch Apr. 12, 2022
-
Patent Title: Method and device for treating sleep apnea Mar. 15, 2022
-
Patent Title: Electrical contacts on a medical device patch Jun. 12, 2018
-
Patent Title: Acred implant unit for modulation of nerves Apr. 24, 2018
-
Patent Title: Method and device for treating sleep apnea based on tongue movement Apr. 17, 2018
-
Patent Title: Devices and methods for low current neural modulation Feb. 20, 2018
-
Patent Title: Transcutaneous power conveyance device Jan. 02, 2018
-
Patent Title: Device and method for snoring detection and control Dec. 26, 2017
-
Patent Title: Flexible control housing for disposable patch May. 09, 2017
-
Patent Title: External resonance matching between an implanted device and an external device Dec. 27, 2016
-
Patent Title: Implant holder and suture guide Dec. 06, 2016
-
Patent Title: Electrical contacts on a medical device patch Nov. 29, 2016
-
Patent Title: Treatment of sleep apnea via bilateral stimulation Oct. 11, 2016
-
Patent Title: Devices for treatment of sleep apnea Aug. 16, 2016
-
Patent Title: Methods for treatment of sleep apnea Aug. 16, 2016
-
Patent Title: Method for controlling energy delivery as a function of degree of coupling Aug. 09, 2016
-
Patent Title: Apparatus and methods for implant coupling indication Aug. 02, 2016
-
Patent Title: Ceramic encapsulation of an implantable device Apr. 12, 2016
-
Patent Title: Devices and methods for delivering energy as a function of condition severity Apr. 05, 2016
-
Patent Title: Antenna buffer layer for an electromagnetic control unit Oct. 13, 2015
-
Patent Title: Flexible antenna on flexible substrate with adhesive back Aug. 04, 2015
-
Patent Title: Dynamic modification of modulation throughout a therapy period Jun. 23, 2015
-
Patent Title: Internal resonance matching between an implanted device and an external device May. 12, 2015
-
Patent Title: Electrical traces in an implant unit Feb. 17, 2015
-
Patent Title: Electrical contacts on a medical device patch Feb. 03, 2015
-
Patent Title: Implant sleep apnea treatment device including an antenna Dec. 02, 2014
-
Patent Title: Insert tool for selectively powering an implant unit Nov. 25, 2014
-
Patent Title: Implant encapsulation Sep. 16, 2014
-
Patent Title: Self resonant transmitting device Sep. 09, 2014
-
Patent Title: Suture holes on a flexible implant Aug. 19, 2014
-
Patent Title: Apparatus and methods for feedback based nerve modulation Aug. 19, 2014
-
Patent Title: Apparatus and method to control an implant May. 06, 2014
-
Patent Title: Devices and methods for low current neural modulation Apr. 15, 2014
-
Patent Title: Electrode configuration for implantable modulator Feb. 04, 2014
-
Patent Title: Device and method for modulating nerves using parallel electric fields Nov. 19, 2013
-
Patent Title: Diagnosis and prediction of obstructive sleep apnea Nov. 19, 2013
-
Patent Title: Antenna providing variable communication with an implant Nov. 05, 2013
-
Patent Title: Systems and methods for determining a sleep disorder based on positioning of the tongue Nov. 05, 2013
-
Patent Title: Apparatus and method for extending implant life using a dual power scheme Nov. 05, 2013
-
Patent Title: Apparatus and method for controlling energy delivery as a function of degree of coupling Nov. 05, 2013
-
Patent Title: System and method for nerve modulation using noncontacting electrodes Nov. 05, 2013
-
Patent Title: Modulator apparatus configured for implantation Nov. 05, 2013
-
Patent Title: Apparatus and methods for feedback-based nerve modulation Nov. 05, 2013
-
Patent Title: Apparatus and method for detecting a sleep disordered breathing precursor Nov. 05, 2013
Federal grants, loans, and purchases
Estimated quarterly amount awarded to NYXH from public contracts
Recent insights relating to NYXH
Recent picks made for NYXH stock on CNBC
ETFs with the largest estimated holdings in NYXH
- ... Highest Price Target
- ... Median Price Target
- ... Lowest Price Target
|
Analyst
|
Firm
|
Current
|
Previous
|
Date
|
|---|
- Is $NYXH stock a Buy, Sell, or Hold?
- What is the price target for $NYXH stock?
* Analyst consensus is not financial advice. Please see our data disclaimers .
|
Shareholder
|
Shares Held
|
|---|
- Who owns $NYXH stock?
- Who owns the most shares of $NYXH stock?
- What funds own $NYXH stock?
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view NYXH Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.
Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.
We estimate that -- received a compensation of -- in --, making them the highest paid executive at NYXH, per a recent SEC DEF 14A filing.
|
Name
|
Role
|
Salary
|
Bonus
|
Stock/Option Awards
|
Total Compensation
|
|---|